CAR-T therapy

WATERTOWN, Massachusetts, USA & DRESDEN, Germany, June 2, 2026 AvenCell Therapeutics has announced that it will present results from...

IRVINE, California, May 29, 2026 PeproMene Bio, Inc. has announced that updated clinical data from its ongoing Phase 1...

BASEL, Switzerland, May 21, 2026 Novartis announced it will present more than 65 company-sponsored and investigator-sponsored abstracts at the...

CAMBRIDGE, Mass., May 12, 2026 Mirai Bio unveiled new preclinical data at the American Society of Gene and Cell...

WELLINGTON, New Zealand – May 6, 2026 BioOra Limited and Wellington Zhaotai Therapies Limited (WZTL) have signed a binding...

BOSTON, Massachusetts, May 2026 Kernal Biologics announced it will present new data on its mRNA 2.0 platform and T-cell-targeted...

CAMBRIDGE, Mass., April 27, 2026 Mirai Bio announced it will unveil two next-generation programs focused on targeted nucleic acid...

Houston, Texas, USA – April 23, 2026 InVita Healthcare Technologies and Gulf Coast Blood announced a major advancement in...

PHILADELPHIA, April 20, 2026 Verismo Therapeutics has reported promising initial Phase 1 clinical data from its STAR-101 trial, evaluating...

INDIANAPOLIS and BOSTON, Mass., April 20, 2026 Eli Lilly and Company has announced a landmark agreement to acquire Kelonia...